These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20970215)

  • 1. Rotational radiotherapy for prostate cancer in clinical practice.
    Aznar MC; Petersen PM; Logadottir A; Lindberg H; Korreman SS; Kjær-Kristoffersen F; Engelholm SA
    Radiother Oncol; 2010 Dec; 97(3):480-4. PubMed ID: 20970215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High dose for prostate irradiation with image guided radiotherapy: contribution of intensity modulation arctherapy].
    Jouyaux F; De Crevoisier R; Manens JP; Bellec J; Cazoulat G; Haigron P; Chira C; Le Prisé E; Lafond C
    Cancer Radiother; 2010 Dec; 14(8):679-89. PubMed ID: 20570202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
    Chen MJ; Weltman E; Hanriot RM; Luz FP; Cecílio PJ; da Cruz JC; Moreira FR; Santos AS; Martins LC; Nadalin W
    Radiat Oncol; 2007 Jan; 2():6. PubMed ID: 17224072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ; van Lin EN; van Kollenburg P; Kunze-Busch M; Kaanders JH
    Radiother Oncol; 2009 Oct; 93(1):131-6. PubMed ID: 19523704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
    Latorzeff I; Mazurier J; Boutry C; Dudouet P; Richaud P; de Crevoisier R
    Cancer Radiother; 2010 Oct; 14(6-7):479-87. PubMed ID: 20797889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
    Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.
    Shaffer R; Morris WJ; Moiseenko V; Welsh M; Crumley C; Nakano S; Schmuland M; Pickles T; Otto K
    Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):401-7. PubMed ID: 19268554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
    Miralbell R; Mollà M; Rouzaud M; Hidalgo A; Toscas JI; Lozano J; Sanz S; Ares C; Jorcano S; Linero D; Escudé L
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):50-7. PubMed ID: 19910135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer.
    Martinez AA; Demanes J; Vargas C; Schour L; Ghilezan M; Gustafson GS
    Am J Clin Oncol; 2010 Oct; 33(5):481-8. PubMed ID: 19952715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter.
    Vassiliev ON; Kry SF; Kuban DA; Salehpour M; Mohan R; Titt U
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1567-71. PubMed ID: 17544596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of out-of-field doses in radiotherapy of brain lesions in children.
    Taylor ML; Kron T; Franich RD
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):927-33. PubMed ID: 20732763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
    Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
    Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma.
    Hayden AJ; Martin JM; Kneebone AB; Lehman M; Wiltshire KL; Skala M; Christie D; Vial P; McDowall R; Tai KH;
    J Med Imaging Radiat Oncol; 2010 Dec; 54(6):513-25. PubMed ID: 21199428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of intensity-modulated radiotherapy for prostate cancer using an empty bladder protocol.
    Tuan JK; Ha TC; Ong WS; Siow TR; Tham IW; Ng WL; Wang ML; Chua ET; Tan TW
    Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):e137-9. PubMed ID: 22795829
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. In regard to Kidd et al. (Int J Radiat Oncol Biol Phys 2010;77:1085-1091.).
    Wei L; Shi M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):636-7; author reply 637. PubMed ID: 20980107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.